Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

Autor: Lorente, D., Mateo, J., Templeton, A.J., Zafeiriou, Z., Bianchini, D., Ferraldeschi, R., Bahl, A., Shen, L., Su, Z., Sartor, O., de Bono, J.S. *
Zdroj: In Annals of Oncology April 2015 26(4):750-755
Databáze: ScienceDirect